ANTICOAGULATION CORONAVIRUS COVID-19 COVID19 INSPIRATION TRIAL PULMONARY EMBOLISM SARS-COV-2 UNCATEGORIZED VENOUS THROMBOEMBOLISM
The INSPIRATION Trial: Intermediate Dose Anticoagulation in Critically Ill Patients with COVID-19

Read more